Lassa Fever: Critical Review and Prospects for Control
Abstract
:1. Lassa Fever: An Overview of the Virology, Clinical Course, and Epidemiology
1.1. Understanding Lassa Virus: Genome, Proteins, and Pathogenesis
1.2. Lassa Fever: Clinical Course and Mortality Rates
1.3. Medical Interventions and Preventive Measures
1.4. Lassa Fever Epidemiology
2. A Devastating Disease in West Africa
3. An Emerging Disease: Historical and Recent Developments in the Spread of Lassa Fever
4. Mapping the Spatial Distribution of Lassa Fever
5. Why Lassa Fever Control Measures Are Failing: Challenges to Disease Management and Prevention
5.1. Viral Diversity
5.2. Inadequate Health System
5.3. Conflicts and Corruption
5.4. Social Stigma, Mistrust, and Misunderstandings
5.5. Delayed Diagnosis and Challenges for Healthcare Workers
6. An Emerging Threat
7. Prospects for Control of Lassa Fever
8. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Frame, J.D.; Baldwin, J.M., Jr.; Gocke, D.J.; Troup, J.M. Lassa Fever, a New Virus Disease of Man from West Africa. Am. J. Trop. Med. Hyg. 1970, 19, 670–676. [Google Scholar] [CrossRef] [PubMed]
- Happi, A.N.; Happi, C.T.; Schoepp, R.J. Lassa fever diagnostics: Past, present, and future. Curr. Opin. Virol. 2019, 37, 132–138. [Google Scholar] [CrossRef]
- Emonet, S.; Lemasson, J.J.; Gonzalez, J.P.; de Lamballerie, X.; Charrel, R.N. Phylogeny and evolution of old world arenaviruses. Virology 2006, 350, 251–257. [Google Scholar] [CrossRef]
- Zapata, J.C.; Salvato, M.S. Arenavirus Variations Due to Host-Specific Adaptation. Viruses 2013, 5, 241–278. [Google Scholar] [CrossRef] [PubMed]
- Andersen, K.G.; Shapiro, B.J.; Matranga, C.B.; Sealfon, R.; Lin, A.E.; Moses, L.M.; Folarin, O.A.; Goba, A.; Odia, I.; Ehiane, P.E.; et al. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell 2015, 162, 738–750. [Google Scholar] [CrossRef] [PubMed]
- Ibukun, F.I. Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development. Viruses 2020, 12, 386. [Google Scholar] [CrossRef] [PubMed]
- Ryu, W.S. Chapter 16—Other Negative-Strand RNA Viruses. In Molecular Virology of Human Pathogenic Viruses; Ryu, W.S., Ed.; Academic Press: Boston, MA, USA, 2017; pp. 213–224. Available online: https://www.sciencedirect.com/science/article/pii/B9780128008386000163 (accessed on 9 August 2024).
- Xing, J.; Ly, H.; Liang, Y. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production. J. Virol. 2015, 89, 2944–2955. [Google Scholar] [CrossRef] [PubMed]
- Zinzula, L.; Tramontano, E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit. Antiviral Res. Antivir. Res. 2013, 100, 615–635. [Google Scholar] [CrossRef] [PubMed]
- Baize, S.; Kaplon, J.; Faure, C.; Pannetier, D.; Georges-Courbot, M.C.; Deubel, V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 2004, 172, 2861–2869. [Google Scholar] [CrossRef]
- Russier, M.; Pannetier, D.; Baize, S. Immune Responses and Lassa Virus Infection. Viruses 2012, 4, 2766–2785. [Google Scholar] [CrossRef]
- Schaeffer, J.; Carnec, X.; Reynard, S.; Mateo, M.; Picard, C.; Pietrosemoli, N.; Dillies, M.-A.; Baize, S. Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells. PLoS Pathog. 2018, 14, e1007430. [Google Scholar] [CrossRef] [PubMed]
- Aloke, C.; Obasi, N.A.; Aja, P.M.; Emelike, C.U.; Egwu, C.O.; Jeje, O.; Edeogu, C.O.; Onisuru, O.O.; Orji, O.U.; Achilonu, I. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives. Viruses 2023, 15, 146. [Google Scholar] [CrossRef]
- Raabe, V.; Mehta, A.K.; Evans, J.D.; Beitscher, A.; Bhadelia, N.; Brett-Major, D.; Cieslak, T.J.; Davey, R.T.; Frank, M.G.; Iwen, P.; et al. Lassa Virus Infection: A Summary for Clinicians. Int. J. Infect. Dis. 2022, 119, 187–200. [Google Scholar] [CrossRef] [PubMed]
- Dan-Nwafor, C.C.; Ipadeola, O.; Smout, E.; Ilori, E.; Adeyemo, A.; Umeokonkwo, C.; Nwidi, D.; Nwachukwu, W.; Ukponu, W.; Omabe, E.; et al. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018. Int. J. Infect. Dis. 2019, 83, 88–94. [Google Scholar] [CrossRef]
- Marrama, E. Rapid Risk Assessment: Lassa fever in Nigeria, Benin, Togo, Germany and USA, 24 March 2016. 2016. Available online: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-lassa-fever-nigeria-benin-togo-germany-and-usa-24-march (accessed on 22 October 2023).
- Basler, C.F. Molecular pathogenesis of viral hemorrhagic fever. Semin. Immunopathol. 2017, 39, 551–561. [Google Scholar] [CrossRef]
- Africa Centres for Disease Control and Prevention. Lassa Fever. Africa CDC. 2018. Available online: https://africacdc.org/disease/lassa-fever/ (accessed on 10 December 2023).
- Yaro, C.A.; Kogi, E.; Opara, K.N.; Batiha, G.E.-S.; Baty, R.S.; Albrakati, A.; Altalbawy, F.M.A.; Etuh, I.U.; Oni, J.P. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria. BMC Infect. Dis. 2021, 21, 149. [Google Scholar] [CrossRef]
- Nigeria Centre for Disease Control. Lassa Fever Situation Report, Epidemiological Week 46. 24 November–1 December 2017; Report No.: 46. 2017. Available online: https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria (accessed on 28 December 2023).
- Grace, J.U.A.; Egoh, I.J.; Udensi, N. Epidemiological trends of Lassa fever in Nigeria from 2015–2021: A review. Ther. Adv. Infect. Dis. 2021, 8, 20499361211058252. [Google Scholar] [CrossRef] [PubMed]
- Nigeria Centre for Disease Control. Lassa Fever Situation Report, Epidemiological Week 52. 24 December–31 December 2018; Report No.: 52. 2018. Available online: https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria (accessed on 28 December 2023).
- UK Health Security Agency (UKHSA), Emerging Infections and Zoonoses (EIZ) Team. Infectious Disease Surveillance and Monitoring for Animal and Human Health: Summary January to June 2023. 2023. Available online: https://www.gov.uk/government/publications/emerging-infections-monthly-summaries/infectious-disease-surveillance-and-monitoring-for-animal-and-human-health-summary-january-to-june-2023 (accessed on 28 December 2023).
- European Centre for Disease Prevention and Control. Lassa Fever in the Netherlands ex Sierra Leone. 2019. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-Lassa-fever-in-the-Netherlands-ex-Sierra-Leone_0.pdf (accessed on 5 May 2020).
- McCormick, J.B. Epidemiology and control of Lassa fever. Curr. Top Microbiol. Immunol. 1987, 134, 69–78. [Google Scholar]
- Richmond, J.K.; Baglole, D.J. Lassa fever: Epidemiology, clinical features, and social consequences. BMJ 2003, 327, 1271–1275. [Google Scholar] [CrossRef]
- Eberhardt, K.A.; Mischlinger, J.; Jordan, S.; Groger, M.; Günther, S.; Ramharter, M. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. Int. J. Infect. Dis. 2019, 87, 15–20. [Google Scholar] [CrossRef]
- Crotty, S.; Maag, D.; Arnold, J.J.; Zhong, W.; Lau, J.Y.N.; Hong, Z.; Andino, R.; Cameron, C.E. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 2000, 6, 1375–1379. [Google Scholar] [CrossRef] [PubMed]
- Crotty, S.; Cameron, C.E.; Andino, R. RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 2001, 98, 6895–6900. [Google Scholar] [CrossRef] [PubMed]
- World Health Organisation. Lassa Fever, Fact Sheets. 2017. Available online: https://www.who.int/news-room/fact-sheets/detail/lassa-fever (accessed on 15 October 2020).
- Bannister, B. Viral haemorrhagic fevers imported into non-endemic countries: Risk assessment and management. Br. Med Bull. 2010, 95, 193–225. [Google Scholar] [CrossRef] [PubMed]
- Alli, A.; Ortiz, J.F.; Fabara, S.P.; Patel, A.; Halan, T. Management of Lassa Fever: A Current Update. Cureus 2021, 13, e14797. [Google Scholar] [CrossRef] [PubMed]
- Warner, B.M.; Safronetz, D.; Stein, D.R. Current research for a vaccine against Lassa hemorrhagic fever virus. Drug Des. Dev. Ther. 2018, 12, 2519–2527. [Google Scholar] [CrossRef] [PubMed]
- Isaac, A.B.; Karolina, W.; Temitope, A.A.; Anuska, R.; Joanne, E.; Deborah, A. Prospects of Lassa fever candidate vaccines. Afr. J. Infect. Dis. 2022, 16, 46–58. [Google Scholar]
- Monath, T.P.; Newhouse, V.F.; Kemp, G.E.; Setzer, H.W.; Cacciapuoti, A. Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone. Science 1974, 185, 263–265. [Google Scholar] [CrossRef] [PubMed]
- Olayemi, A.; Oyeyiola, A.; Obadare, A.; Igbokwe, J.; Adesina, A.S.; Onwe, F.; Ukwaja, K.N.; Ajayi, N.A.; Rieger, T.; Günther, S.; et al. Widespread arenavirus occurrence and seroprevalence in small mammals, Nigeria. Parasites Vectors 2018, 11, 416. [Google Scholar] [CrossRef] [PubMed]
- Oloniniyi, O.K.; Unigwe, U.S.; Okada, S.; Kimura, M.; Koyano, S.; Miyazaki, Y.; Iroezindu, M.O.; Ajayi, N.A.; Chukwubike, C.M.; Chika-Igwenyi, N.M.; et al. Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLoS Neglected Trop. Dis. 2018, 12, e0006971. [Google Scholar] [CrossRef]
- Kafetzopoulou, L.E.; Pullan, S.T.; Lemey, P.; Suchard, M.A.; Ehichioya, D.U.; Pahlmann, M.; Thielebein, A.; Hinzmann, J.; Oestereich, L.; Wozniak, D.M.; et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 2019, 363, 74–77. [Google Scholar] [CrossRef]
- World Health Organisation. Lassa Fever—Nigeria. WHO Disease Outbreak News. 2023. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON463 (accessed on 10 December 2023).
- Bonwitt, J.; Kelly, A.H.; Ansumana, R.; Agbla, S.; Sahr, F.; Saez, A.M.; Borchert, M.; Kock, R.; Fichet-Calvet, E. Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever. Ecohealth 2016, 13, 234–247. [Google Scholar] [CrossRef] [PubMed]
- Ter Meulen, J.; Lukashevich, I.; Sidibe, K.; Inapogui, A.; Marx, M.; Dorlemann, A.; Yansane, M.L.; Koulemou, K.; Chang-Claude, J.; Schmitz, H. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am. J. Trop. Med. Hyg. 1996, 55, 661–666. [Google Scholar] [CrossRef] [PubMed]
- Douno, M.; Asampong, E.; Magassouba, N.; Fichet-Calvet, E.; Almudena, M.S. Hunting and consumption of rodents by children in the Lassa fever endemic area of Faranah, Guinea. PLoS Negl. Trop Dis. 2021, 15, e0009212. [Google Scholar] [CrossRef]
- Terashima, H.; Hewlett, B.S. Social Learning and Innovation in Contemporary Hunter-Gatherers: Evolutionary and Ethnographic Perspectives; Springer: Tokyo, Japan, 2016; 314p. [Google Scholar]
- Kernéis, S.; Koivogui, L.; Magassouba, N.; Koulemou, K.; Lewis, R.; Aplogan, A.; Grais, R.F.; Guerin, P.J.; Fichet-Calvet, E. Prevalence and Risk Factors of Lassa Seropositivity in Inhabitants of the Forest Region of Guinea: A Cross-Sectional Study. PLoS Negl. Trop Dis. 2009, 3, e548. [Google Scholar] [CrossRef]
- Pfau, C.J. Arenaviruses. In Medical Microbiology, 4th ed.; University of Texas Medical Branch at Galveston: Galveston, TX, USA, 1996. Available online: https://www.ncbi.nlm.nih.gov/books/NBK8193/ (accessed on 11 April 2020).
- Abdullahi, I.N.; Anka, A.U.; Ghamba, P.E.; Onukegbe, N.B.; Amadu, D.O.; Salami, M.O. Need for preventive and control measures for Lassa fever through the One Health strategic approach. Proc. Singap. Health 2020, 29, 190–194. [Google Scholar] [CrossRef]
- Cadmus, S.; Taiwo, O.J.; Akinseye, V.; Cadmus, E.; Famokun, G.; Fagbemi, S.; Ansumana, R.; Omoluabi, A.; Ayinmode, A.; Oluwayelu, D.; et al. Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017–2021: An emerging urban trend. Sci. Rep. 2023, 13, 20855. [Google Scholar] [CrossRef] [PubMed]
- Dalhat, M.M.; Olayinka, A.; Meremikwu, M.M.; Dan-Nwafor, C.; Iniobong, A.; Ntoimo, L.F.; Onoh, I.; Mba, S.; Ohonsi, C.; Arinze, C.; et al. Epidemiological trends of Lassa fever in Nigeria, 2018–2021. PLoS ONE 2022, 17, e0279467. [Google Scholar] [CrossRef]
- Bonner, P.C.; Schmidt, W.-P.; Belmain, S.R.; Borchert, M.; Oshin, B.; Baglole, D. Poor Housing Quality Increases Risk of Rodent Infestation and Lassa Fever in Refugee Camps of Sierra Leone. Am. J. Trop. Med. Hyg. 2007, 77, 169–175. [Google Scholar] [CrossRef]
- Malik, S.; Bora, J.; Dhasmana, A.; Kishore, S.; Nag, S.; Preetam, S.; Uniyal, P.; Slama, P.; Mukherjee, N.; Haque, S.; et al. An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks. Int. J. Surg. Lond. Engl. 2023, 109, 584–586. [Google Scholar] [CrossRef]
- McKendrick, J.Q.; Tennant, W.S.D.; Tildesley, M.J. Modelling seasonality of Lassa fever incidences and vector dynamics in Nigeria. PLoS Negl Trop Dis. 2023, 17, e0011543. [Google Scholar] [CrossRef]
- Nigeria Centre for Disease Control. Lassa Fever Situation Report, Epidemiological Week 29. 17 July–23 July 2023; Report No.: 29. Available online: https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria (accessed on 9 August 2024).
- Fisher-Hoch, S.P.; Tomori, O.; Nasidi, A.; Perez-Oronoz, I.G.; Fakile, Y.; Hutwagner, L.; McCormick, J.B. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. BMJ 1995, 311, 857–859. [Google Scholar] [CrossRef]
- du Plessis, J.; Russo, I.; Child, M. A conservation assessment of Mastomys spp. In The Red List of Mammals of South Africa, Swaziland and Lesotho; Child, M.F., Roxburgh, L., Do Linh San, E., Eds.; South African National Biodiversity Institute and Endangered Wildlife Trust: Pretoria, South Africa, 2016; pp. 1–7. [Google Scholar]
- Schmaljohn, C.; Safronetz, D. Editorial overview: Lassa virus. Curr. Opin. Virol. 2019, 37, VII–IX. [Google Scholar] [CrossRef] [PubMed]
- Simons, D. Lassa fever cases suffer from severe underreporting based on reported fatalities. Int. Health 2022, 15, 608–610. [Google Scholar] [CrossRef] [PubMed]
- Shaffer, J.G.; Grant, D.S.; Schieffelin, J.S.; Boisen, M.L.; Goba, A.; Hartnett, J.N.; Levy, D.C.; Yenni, R.E.; Moses, L.M.; Fullah, M.; et al. Lassa Fever in Post-Conflict Sierra Leone. PLoS Negl. Trop. Dis. 2014, 8, e2748. [Google Scholar] [CrossRef] [PubMed]
- Price, M.E.; Fisher-Hoch, S.P.; Craven, R.B.; McCormick, J.B. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 1988, 297, 584–587. [Google Scholar] [CrossRef] [PubMed]
- Cummins, D.; McCormick, J.B.; Bennett, D.; Samba, J.A.; Farrar, B.; Machin, S.J.; Fisher-Hoch, S.P. Acute Sensorineural Deafness in Lassa Fever. J. Am. Med. Assoc. 1990, 264, 2093–2096. [Google Scholar] [CrossRef]
- Liao, B.S.; Byl, F.M.; Adour, K.K. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: Evidence for viral cause. Otolaryngol. Head Neck Surg. 1992, 106, 226–229. [Google Scholar] [CrossRef] [PubMed]
- Mateer, E.J.; Huang, C.; Shehu, N.Y.; Paessler, S. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden. PLoS Negl. Trop Dis. 2018, 12, e0006187. [Google Scholar] [CrossRef] [PubMed]
- McPherson, B.; Brouillette, R. Audiology in Developing Countries; Nova Science Publishers, Inc.: New York, NY, USA, 2008; 1p. [Google Scholar]
- Macher, A.M.; Wolfe, M.S. Historical Lassa Fever Reports and 30-year Clinical Update. Emerg. Infect. Dis. 2006, 12, 835–837. [Google Scholar] [CrossRef]
- Okogbenin, E.O.; Obagaye, M.O.; Aweh, B.E.; Eriyo, W.O.; Okogbenin, S.A.; Okokhere, P.O. One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria. Emerg. Infect. Dis. 2020, 26, 3091–3093. [Google Scholar] [CrossRef]
- Monath, T.P. Lassa fever: Review of epidemiology and epizootiology. Bull. World Health Organ. 1975, 52, 577–592. [Google Scholar] [PubMed]
- Manning, J.T.; Forrester, N.; Paessler, S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front. Microbiol. 2015, 6, 1037. [Google Scholar] [CrossRef] [PubMed]
- Lalis, A.; Leblois, R.; Lecompte, E.; Denys, C.; ter Meulen, J.; Wirth, T. The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa. PLoS ONE 2012, 7, e37068. [Google Scholar] [CrossRef]
- Nigeria Centre for Disease Control. Lassa Fever Situation Report, Epidemiological Week 52. 27 December 2020–2 January 2021; Report No.: 52. 2021. Available online: https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria (accessed on 10 December 2023).
- Nigeria Centre for Disease Control. Lassa Fever Situation Report, Epidemiological Week 52; Report No.: 52. 2023. Available online: https://ncdc.gov.ng/diseases/sitreps/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria (accessed on 10 May 2024).
- Africa Centres for Disease Control and Prevention. Africa CDC Weekly Event Based Surveillance Report, June 2024. 2024. Available online: https://africacdc.org/download/africa-cdc-weekly-event-based-surveillance-report-june-2024/ (accessed on 21 July 2024).
- Whitmer, S.L.; Strecker, T.; Cadar, D.; Dienes, H.P.; Faber, K.; Patel, K.; Brown, S.M.; Davis, W.G.; Klena, J.D.; Rollin, P.E.; et al. New Lineage of Lassa Virus, Togo, 2016. Emerg. Infect. Dis. 2018, 24, 599–602. [Google Scholar] [CrossRef] [PubMed]
- Emmerich, P.; Thome-Bolduan, C.; Drosten, C.; Gunther, S.; Ban, E.; Sawinsky, I.; Schmitz, H. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. J. Clin. Virol. 2006, 37, 277–281. [Google Scholar] [CrossRef] [PubMed]
- Dzotsi, E.K.; Ohene, S.-A.; Asiedu-Bekoe, F.; Amankwa, J.; Sarkodie, B.; Adjabeng, M.; Thouphique, A.M.; Ofei, A.; Oduro, J.; Atitogo, D.; et al. The First Cases of Lassa Fever in Ghana. Ghana Med. J. 2012, 46, 166–170. [Google Scholar] [PubMed]
- Centres for Disease Control and Prevention. Outbreak Distribution Map|Lassa Fever|CDC. 2014. Available online: https://www.cdc.gov/lassa-fever/about/index.html (accessed on 9 August 2024).
- Atkin, S.; Anaraki, S.; Gothard, P.; Walsh, A.; Brown, D.; Gopal, R.; Hand, J.; Morgan, D. The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Eurosurveillance 2009, 14, 19145. [Google Scholar] [CrossRef] [PubMed]
- World Health Organisation Regional Office for Africa. Weekly Bulletin on Outbreak and other Emergencies: Week 47: 18–24 November 2019. 2019. Available online: https://iris.who.int/handle/10665/329974 (accessed on 23 December 2023).
- Africa Centres for Disease Control and Prevention. Africa CDC Weekly Event Based Surveillance Report, 17 February 2024. Available online: https://africacdc.org/download/africa-cdc-weekly-event-based-surveillance-report-february-2023/ (accessed on 9 August 2024).
- Mylne, A.Q.N.; Pigott, D.M.; Longbottom, J.; Shearer, F.; Duda, K.A.; Messina, J.P.; Weiss, D.J.; Moyes, C.L.; Golding, N.; Hay, S.I. Mapping the zoonotic niche of Lassa fever in Africa. Trans. R. Soc. Trop. Med. Hyg. 2015, 109, 483–492. [Google Scholar] [CrossRef] [PubMed]
- Colangelo, P.; Verheyen, E.; Leirs, H.; Tatard, C.; Denys, C.; Dobigny, G.; Duplantier, J.-M.; Brouat, C.; Granjon, L.; Lecompte, E. A mitochondrial phylogeographic scenario for the most widespread African rodent, Mastomys natalensis. Biol. J. Linn. Soc. 2013, 108, 901–916. [Google Scholar] [CrossRef]
- Granjon, L. Mastomys natalensis. IUCN Red List Threat Species. 2016. Available online: https://www.iucnredlist.org/species/12868/115107375 (accessed on 12 May 2024).
- Redding, D.W.; Moses, L.M.; Cunningham, A.A.; Wood, J.; Jones, K.E. Environmental-Mechanistic Modelling of the Impact of Global Change on Human Zoonotic 2 Disease Emergence: A Case Study of Lassa Fever. Macro-Mechanistic Modelling of Zoonotic Disease Emergence. 2016. Available online: https://www.repository.cam.ac.uk/handle/1810/256060 (accessed on 17 April 2020).
- Gibb, R.; Moses, L.M.; Redding, D.W.; Jones, K.E. Understanding the cryptic nature of Lassa fever in West Africa. Ann. Trop. Med. Parasitol. 2017, 111, 276–288. [Google Scholar] [CrossRef] [PubMed]
- Happi, A.N.; Olumade, T.J.; Ogunsanya, O.A.; Sijuwola, A.E.; Ogunleye, S.C.; Oguzie, J.U.; Nwofoke, C.; Ugwu, C.A.; Okoro, S.J.; Otuh, P.I.; et al. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria. Microbiol. Spectr. 2022, 10, e0036622. [Google Scholar] [CrossRef] [PubMed]
- Adetola, O.O.; Adebisi, M.A. Impacts of Deforestation on the Spread of Mastomys natalensis in Nigeria. World Sci. News 2019, 11, 286–296. [Google Scholar]
- Wulff, H.; Fabiyi, A.; Monath, T.P. Recent isolations of Lassa virus from Nigerian rodents. Bull. World Health Organ. 1975, 52, 609–613. [Google Scholar] [PubMed]
- Demby, A.H.; Inapogui, A.; Kargbo, K.; Koninga, J.; Kourouma, K.; Kanu, J.; Coulibaly, M.; Wagoner, K.D.; Ksiazek, T.G.; Peters, C.; et al. Lassa Fever in Guinea: II. Distribution and Prevalence of Lassa Virus Infection in Small Mammals. Vector-Borne Zoonotic Dis. 2001, 1, 283–297. [Google Scholar] [CrossRef] [PubMed]
- Fichet-Calvet, E.; Becker-Ziaja, B.; Koivogui, L.; Günther, S. Lassa Serology in Natural Populations of Rodents and Horizontal Transmission. Vector-Borne Zoonotic Dis. 2014, 14, 665–674. [Google Scholar] [CrossRef] [PubMed]
- Gryseels, S.; Baird, S.J.E.; Borremans, B.; Makundi, R.; Leirs, H.; de Bellocq, J.G. When Viruses Don’t Go Viral: The Importance of Host Phylogeographic Structure in the Spatial Spread of Arenaviruses. PLoS Pathog. 2017, 13, e1006073. [Google Scholar] [CrossRef]
- Lalis, A.; Wirth, T. 11—Mice and Men: An Evolutionary History of Lassa Fever. In Biodiversity and Evolution; Grandcolas, P., Maurel, M.C., Eds.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 189–212. Available online: http://www.sciencedirect.com/science/article/pii/B9781785482779500115 (accessed on 15 February 2020).
- Klitting, R.; Kafetzopoulou, L.E.; Thiery, W.; Dudas, G.; Gryseels, S.; Kotamarthi, A.; Vrancken, B.; Gangavarapu, K.; Momoh, M.; Sandi, J.D.; et al. Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades. Nat. Commun. 2022, 13, 5596. [Google Scholar] [CrossRef] [PubMed]
- Happi, A.N.; Ogunsanya, O.A.; Ayinla, A.O.; Sijuwola, A.E.; Saibu, F.M.; Akano, K.; Nwofoke, C.; Elias, O.T.; Achonduh-Atijegbe, O.; Daodu, R.O.; et al. Lassa virus in novel hosts: Insights into the epidemiology of lassa virus infections in southern Nigeria. Emerg. Microbes Infect. 2024, 13, 2294859. [Google Scholar] [CrossRef]
- Arruda, L.B.; Free, H.B.; Simons, D.; Ansumana, R.; Elton, L.; Haider, N.; Honeyborne, I.; Asogun, D.; McHugh, T.D.; Ntoumi, F.; et al. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions. PLoS Glob. Public Health 2023, 3, e0002159. [Google Scholar] [CrossRef]
- Li, Y. Genetic basis underlying Lassa fever endemics in the Mano River region, West Africa. Virology 2023, 579, 128–136. [Google Scholar] [CrossRef] [PubMed]
- Olayemi, A.; Cadar, D.; Magassouba, N.; Obadare, A.; Kourouma, F.; Oyeyiola, A.; Fasogbon, S.; Igbokwe, J.; Rieger, T.; Bockholt, S.; et al. New Hosts of The Lassa Virus. Sci. Rep. 2016, 6, 25280. [Google Scholar] [CrossRef] [PubMed]
- Ehichioya, D.U.; Dellicour, S.; Pahlmann, M.; Rieger, T.; Oestereich, L.; Becker-Ziaja, B.; Cadar, D.; Ighodalo, Y.; Olokor, T.; Omomoh, E.; et al. Phylogeography of Lassa Virus in Nigeria. J. Virol. 2019, 93, e00929-19. [Google Scholar] [CrossRef] [PubMed]
- Clegg, J.C.; Lloyd, G. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet 1987, 330, 186–188. [Google Scholar] [CrossRef] [PubMed]
- Hallam, H.J.; Hallam, S.; Rodriguez, S.E.; Barrett, A.D.; Beasley, D.W.; Chua, A.; Ksiazek, T.G.; Milligan, G.N.; Sathiyamoorthy, V.; Reece, L.M. Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. NPJ Vaccines 2018, 3, 11. [Google Scholar] [CrossRef]
- Akokuwebe, M.E.; Idemudia, E.S. A Comparative Cross-Sectional Study of the Prevalence and Determinants of Health Insurance Coverage in Nigeria and South Africa: A Multi-Country Analysis of Demographic Health Surveys. Int. J. Environ. Res. Public Health 2022, 19, 1766. [Google Scholar] [CrossRef] [PubMed]
- Sasu. Nigeria: Health Insurance Coverage, by Area and Gender|Statista. 2022. Available online: https://www.statista.com/statistics/1124757/health-insurance-coverage-in-nigeria-by-area-and-gender/ (accessed on 24 December 2023).
- World Bank. Nigeria Overview: Development News, Research, Data. 2023. Available online: https://www.worldbank.org/en/country/nigeria/overview (accessed on 24 December 2023).
- Okpani, A.I.; Abimbola, S. Operationalizing universal health coverage in Nigeria through social health insurance. Niger. Med J. 2015, 56, 305–310. [Google Scholar] [CrossRef] [PubMed]
- Eke, C. Nigeria—Healthcare. Official Website of the USA International Trade Association. 2023. Available online: https://www.trade.gov/country-commercial-guides/nigeria-healthcare (accessed on 24 December 2023).
- United Nations Development Programme. HDR21-22_Statistical_Annex_HDI_Table.xlsx. 2022. Available online: https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fhdr.undp.org%2Fsites%2Fdefault%2Ffiles%2F2021-22_HDR%2FHDR21-22_Statistical_Annex_HDI_Table.xlsx&wdOrigin=BROWSELINK (accessed on 27 December 2023).
- Onwujekwe, O.; Agwu, P.; Orjiakor, C.; McKee, M.; Hutchinson, E.; Mbachu, C.; Odii, A.; Ogbozor, P.; Obi, U.; Ichoku, H.; et al. Corruption in Anglophone West Africa health systems: A systematic review of its different variants and the factors that sustain them. Heal. Policy Plan. 2019, 34, 529–543. [Google Scholar] [CrossRef]
- Ogueji, I.A.; Ogunsola, O.O.; Abdalla, N.M.; Helmy, M. Mistrust of the Nigerian health system and its practical implications: Qualitative insights from professionals and non-professionals in the Nigerian health system. J. Public Health 2024, 32, 303–314. [Google Scholar] [CrossRef]
- Wogu, J.O. Mass media awareness campaign and the prevention of the spread of Lassa fever in the rural communities of Ebonyi State, Nigeria: Impact evaluation. J. Public Health Afr. 2018, 9, 179–184. [Google Scholar] [CrossRef]
- Bonwitt, J.; Dawson, M.; Kandeh, M.; Ansumana, R.; Sahr, F.; Brown, H.; Kelly, A.H. Unintended consequences of the ‘bushmeat ban’ in West Africa during the 2013–2016 Ebola virus disease epidemic. Soc. Sci. Med. 2018, 200, 166–173. [Google Scholar] [CrossRef] [PubMed]
- Woyessa, A.B.; Maximore, L.; Keller, D.; Dogba, J.; Pajibo, M.; Johnson, K.; Saydee, E.; Monday, J.; Tuopileyi, R.; Mahmoud, N. Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: Case report. BMC Infect. Dis. 2019, 19, 610. [Google Scholar]
- Schroeder, L.F.; Amukele, T. Medical Laboratories in Sub-Saharan Africa That Meet International Quality Standards. Am. J. Clin. Pathol. 2014, 141, 791–795. [Google Scholar] [CrossRef] [PubMed]
- Boisen, M.L.; Uyigue, E.; Aiyepada, J.; Siddle, K.J.; Oestereich, L.; Nelson, D.K.S.; Bush, D.J.; Rowland, M.M.; Heinrich, M.L.; Eromon, P.; et al. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Sci. Rep. 2020, 10, 8724. [Google Scholar] [CrossRef]
- Mazzola, L.T.; Kelly-Cirino, C. Diagnostics for Lassa fever virus: A genetically diverse pathogen found in low-resource settings. BMJ Glob. Health 2019, 4 (Suppl. 2), e001116. [Google Scholar] [CrossRef]
- Akpede, G.O.; Asogun, D.A.; Okogbenin, S.A.; Dawodu, S.O.; Momoh, M.O.; Dongo, A.E.; Ike, C.; Tobin, E.; Akpede, N.; Ogbaini-Emovon, E.; et al. Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center’s Experience and Its Implications. Front. Public Health 2019, 7, 170. [Google Scholar]
- Ijarotimi, I.T.; Ilesanmi, O.S.; Aderinwale, A.; Abiodun-Adewusi, O.; Okon, I.M. Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria. Pan. Afr. Med. J. 2018, 30, 56. [Google Scholar] [PubMed]
- Avenant, N.L.; Watson, J.P.; Schulze, E. Correlating small mammal community characteristics and habitat integrity in the Caledon Nature Reserve, South Africa. Mammalia 2008, 72, 186–191. [Google Scholar] [CrossRef]
- MacFadyen, D.N.; Avenant, N.L.; van der Merwe, M.; Bredenkamp, G.J. The Influence of Fire on Rodent Abundance at the N’washitshumbe Enclosure Site, Kruger National Park, South Africa. Afr. Zool. 2012, 47, 138–146. [Google Scholar]
- Balogun, O.O.; Akande, O.W.; Hamer, D.H. Lassa Fever: An Evolving Emergency in West Africa. Am. J. Trop. Med. Hyg. 2021, 104, 466–473. [Google Scholar] [CrossRef]
- Wolf, T.; Ellwanger, R.; Goetsch, U.; Wetzstein, N.; Gottschalk, R. Fifty years of imported Lassa fever: A systematic review of primary and secondary cases. J. Travel Med. 2020, 27, taaa035. [Google Scholar] [CrossRef] [PubMed]
- World Health Organisation. Lassa Fever—United Kingdom of Great Britain and Northern Ireland. Disease Outbreak News. 2022. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/lassa-fever-united-kingdom-of-great-britain-and-northern-ireland (accessed on 27 December 2023).
- Grant, D.S.; Samuels, R.J.; Garry, R.F.; Schieffelin, J.S. Lassa Fever Natural History and Clinical Management. Curr. Top Microbiol. Immunol. 2023, 440, 165–192. [Google Scholar]
- Brosh-Nissimov, T. Lassa fever: Another threat from West Africa. Disaster Mil. Med. 2016, 2, 8. [Google Scholar] [CrossRef]
- Tuite, A.R.; Watts, A.G.; Kraemer, M.U.G.; Khan, K.; Bogoch, I.I. Potential for Seasonal Lassa Fever Case Exportation from Nigeria. Am. J. Trop. Med. Hyg. 2019, 100, 647–651. [Google Scholar] [CrossRef]
- World Health Organisation. Lassa Fever—Germany. Disease Outbreak News. 2016. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/23-march-2016-lassa-fever-germany-en (accessed on 28 December 2023).
- World Health Organisation. Lassa Fever—Togo. Disease Outbreak News. 2016. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/23-march-2016-lassa-fever-togo-en (accessed on 28 December 2023).
- Njuguna, C.; Vandi, M.; Liyosi, E.; Githuku, J.; Wurie, A.; Njeru, I.; Raftery, P.; Amuzu, C.; Maruta, A.; Musoke, R.; et al. A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands. Int. J. Infect. Dis. 2022, 117, 295–301. [Google Scholar] [CrossRef] [PubMed]
- Ihekweazu, C. National Guidelines for Lassa Fever Case Management. 2018. Available online: https://ncdc.gov.ng/themes/common/docs/protocols/92_1547068532.pdf (accessed on 28 December 2023).
- Mehand, M.S.; Al-Shorbaji, F.; Millett, P.; Murgue, B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antivir. Res. 2018, 159, 63–67. [Google Scholar] [PubMed]
- World Health Organisation. Prioritizing Diseases for Research and Development in Emergency Contexts. 2023. Available online: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts (accessed on 11 June 2020).
- Bernasconi, V.; Kristiansen, P.A.; Whelan, M.; Román, R.G.; Bettis, A.; Yimer, S.A.; Gurry, C.; Andersen, S.R.; Yeskey, D.; Mandi, H.; et al. Developing vaccines against epidemic-prone emerging infectious diseases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020, 63, 65–73. [Google Scholar] [CrossRef] [PubMed]
- CEPI. Testing the Tests: Scientists Seek Out Best on-the-Spot Diagnostics for Deadly Nipah and Lassa. CEPI Official Website. 2024. Available online: https://cepi.net//testing-tests-scientists-seek-out-best-spot-diagnostics-deadly-nipah-and-lassa (accessed on 21 July 2024).
- Epidemic Preparedness Innovations. Enable Epi Study—Epidemic Preparedness Innovations. The Global Health Network. 2024. Available online: https://epi.tghn.org/epidemiology/epi-studies/ (accessed on 21 July 2024).
- Goios, A.; Varma, A.; Kagia, C.; Otiende, M.; Suykerbuyk, P. Enable Lassa Research Programme Mid-Term Workshop; The Global Health Network: Abuja, Nigeria, 2022. [Google Scholar]
- The West Africa Lassa Fever Consortium. A Clinical Development Strategy to Deliver New Lassa Fever Therapeutics. 2023. Available online: https://isaricdev.wpenginepowered.com/wp-content/uploads/2023/03/A-Clinical-Development-Strategy-to-Deliver-New-Lassa-Fever-Therapeutics.pdf (accessed on 9 August 2024).
- Mueller-Langer, F. Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? Health Econ. Policy Law 2013, 8, 185–208. [Google Scholar] [CrossRef]
- Garry, R.F. Lassa fever—The road ahead. Nat. Rev. Microbiol. 2023, 21, 87–96. [Google Scholar] [CrossRef]
- Melnik, L.I. Lassa Virus Countermeasures. Curr. Top Microbiol. Immunol. 2023, 440, 111–145. [Google Scholar]
- Furuta, Y.; Komeno, T.; Nakamura, T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc. Jpn. Acad. Ser. B 2017, 93, 449–463. [Google Scholar] [CrossRef]
- Oestereich, L.; Rieger, T.; Lüdtke, A.; Ruibal, P.; Wurr, S.; Pallasch, E.; Bockholt, S.; Krasemann, S.; Muñoz-Fontela, C.; Günther, S. Efficacy of Favipiravir Alone and in Combination with Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever. J. Infect. Dis. 2016, 213, 934–938. [Google Scholar] [CrossRef] [PubMed]
- Rosenke, K.; Feldmann, H.; Westover, J.B.; Hanley, P.W.; Martellaro, C.; Feldmann, F.; Saturday, G.; Lovaglio, J.; Scott, D.P.; Furuta, Y.; et al. Use of Favipiravir to Treat Lassa Virus Infection in Macaques. Emerg. Infect. Dis. 2018, 24, 1696–1699. [Google Scholar] [CrossRef] [PubMed]
- Raabe, V.N.; Kann, G.; Ribner, B.S.; Morales, A.; Varkey, J.B.; Mehta, A.K.; Lyon, G.M.; Vanairsdale, S.; Faber, K.; Becker, S.; et al. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. Clin. Infect. Dis. 2017, 65, 855–859. [Google Scholar] [CrossRef] [PubMed]
- Cashman, K.A.; Wilkinson, E.R.; Posakony, J.; Madu, I.G.; Tarcha, E.J.; Lustig, K.H.; Korth, M.J.; Bedard, K.M.; Amberg, S.M. Lassa antiviral LHF-535 protects guinea pigs from lethal challenge. Sci. Rep. 2022, 12, 19911. [Google Scholar] [CrossRef] [PubMed]
- Amberg, S.M.; Snyder, B.; Vliet-Gregg, P.A.; Tarcha, E.J.; Posakony, J.; Bedard, K.M.; Heald, A.E. Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults. Antimicrob. Agents Chemother. 2022, 66, e0095122. [Google Scholar] [CrossRef] [PubMed]
- Gowen, B.B.; Smee, D.F.; Wong, M.-H.; Pace, A.M.; Jung, K.-H.; Bailey, K.W.; Blatt, L.M.; Sidwell, R.W. Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters. Antivir. Chem. Chemother. 2006, 17, 175–183. [Google Scholar] [CrossRef] [PubMed]
- Baize, S.; Marianneau, P.; Loth, P.; Reynard, S.; Journeaux, A.; Chevallier, M.; Tordo, N.; Deubel, V.; Contamin, H. Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys. J. Virol. 2009, 83, 5890–5903. [Google Scholar] [CrossRef]
- Cross, R.W.; Heinrich, M.L.; Fenton, K.A.; Borisevich, V.; Agans, K.N.; Prasad, A.N.; Woolsey, C.; Deer, D.J.; Dobias, N.S.; Rowland, M.M.; et al. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proc. Natl. Acad. Sci. USA 2023, 120, e2304876120. [Google Scholar] [CrossRef]
- Cross, R.W.; Fenton, K.A.; Woolsey, C.; Prasad, A.N.; Borisevich, V.; Agans, K.N.; Deer, D.J.; Dobias, N.S.; Fears, A.C.; Heinrich, M.L.; et al. Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus. Cell Rep. Med. 2024, 5, 101392. [Google Scholar] [CrossRef]
- ALIMA. First-Ever Global Alliance of Researchers, Health Workers, and Humanitarians Join Forces to Fight the Deadly Lassa Fever Virus. ALIMA—The Alliance for Medical Action. 2024. Available online: https://alima.ngo/en/press-releases/lassa-fever-alliance-virus/ (accessed on 21 July 2024).
- Sulis, G.; Peebles, A.; Basta, N.E. Lassa fever vaccine candidates: A scoping review of vaccine clinical trials. Trop. Med. Int. Health 2023, 28, 420–431. [Google Scholar] [CrossRef]
- Moore, K.A.; Ostrowsky, J.T.; Mehr, A.J.; Johnson, A.R.; Ulrich, A.K.; Moua, N.M.; Fay, P.C.; Hart, P.J.; Golding, J.P.; Benassi, V.; et al. Lassa fever research priorities: Towards effective medical countermeasures by the end of the decade. Lancet Infect. Dis. 2024. ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Mateo, M.; Reynard, S.; Carnec, X.; Journeaux, A.; Baillet, N.; Schaeffer, J.; Picard, C.; Legras-Lachuer, C.; Allan, R.; Perthame, E.; et al. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Sci. Transl. Med. 2019, 11, eaaw3163. [Google Scholar] [CrossRef] [PubMed]
- Mateo, M.; Reynard, S.; Pietrosemoli, N.; Perthame, E.; Journeaux, A.; Noy, K.; Germain, C.; Carnec, X.; Picard, C.; Borges-Cardoso, V.; et al. Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys. Nat. Commun. 2023, 14, 1352. [Google Scholar] [CrossRef]
- Tschismarov, R.; Van Damme, P.; Germain, C.; De Coster, I.; Mateo, M.; Reynard, S.; Journeaux, A.; Tomberger, Y.; Withanage, K.; Haslwanter, D.; et al. Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: A randomised, placebo-controlled, first-in-human trial. Lancet 2023, 401, 1267–1276. [Google Scholar] [CrossRef]
- ClinicalTrials. No Study Results Posted|Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers. ClinicalTrials.gov (US Government). 2020. Available online: https://clinicaltrials.gov/study/NCT03805984?tab=results (accessed on 21 July 2024).
- Marrero, I. INO 4500, a DNA Based LASV Vaccine, Induces Robust T Cell Responses and Long-Term Memory Antigen-Specific T Cells|Vaccines Conferences|International Vaccines Congress. 2021. Available online: https://vaccinescongress.com/program/scientific-program/2021/ino-4500-a-dna-based-lasv-vaccine-induces-robust-t-cell-responses-and-long-term-memory-antigen-specific-t-cells (accessed on 9 August 2024).
- INOVIO Pharmaceuticals, Inc. INOVIO Provides an Update on Lassa Fever and MERS Programs. 2022. Available online: https://ir.inovio.com/news-releases/news-releases-details/2022/INOVIO-Provides-an-Update-on-Lassa-Fever-and-MERS-Programs/default.aspx (accessed on 9 August 2024).
- Baden, M.; Kieh, L.; Fitz-Patrick, D.; Diemert, D.; Mutua, G. First Safety & Immunogenicity Data from a FIH, Placebo-Controlled, Dose-Escalation Trial of a Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine in Healthy Adults. 2023. Available online: https://www.iavi.org/wp-content/uploads/2023/11/C102_ASTMH_Poster_Chicago2023.pdf (accessed on 21 July 2024).
- Abiola, A. Time to Hope for a Lassa Fever Vaccine? GAVI, the Vaccine Alliance. 2024. Available online: https://www.gavi.org/vaccineswork/time-hope-lassa-fever-vaccine (accessed on 21 July 2024).
- Pan African Clinical Trials Registry. A Phase 1 Randomized, Blinded, Placebo Controlled, Dose-Escalation and Dosing Regimen Selection Study to Evaluate the Safety and Immunogenicity of rVSV-Vectored Lassa Virus Vaccine in Healthy Adults at Multiple Sites in West Africa. Pan African Clinical Trials Registry. 2021. Available online: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14618 (accessed on 21 July 2024).
- Fahrni, M.L.; Ismail, I.A.-N.; Refi, D.M.; Almeman, A.; Yaakob, N.C.; Saman, K.M.; Mansor, N.F.; Noordin, N.; Babar, Z.-U. Management of COVID-19 vaccines cold chain logistics: A scoping review. J. Pharm. Policy Pr. 2022, 15, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Leach, M.; Fairhead, J. Understandings of immunization: Some west African perspectives. Bull World Health Organ. 2008, 86, 418. [Google Scholar] [CrossRef] [PubMed]
- Agbede, G.T.; Emezirinwune, D.; Adedokun, T.; Idowu-Collins, P. Vaccine Hesitancy in Nigeria: Overcoming Cultural, Linguistic and Religious Obstacles. Inf. Impact J. Inf. Knowl. Manag. 2024, 15, 153–168. [Google Scholar] [CrossRef]
- Michael, C.A.; Ogbuanu, I.U.; Storms, A.D.; Ohuabunwo, C.J.; Corkum, M.; Ashenafi, S.; Achari, P.; Biya, O.; Nguku, P.; Mahoney, F.; et al. An Assessment of the Reasons for Oral Poliovirus Vaccine Refusals in Northern Nigeria. J. Infect. Dis. 2014, 210, S125–S130. [Google Scholar] [CrossRef]
- World Health Organisation. Report of the SAGE Working Group on Vaccine Hesitancy. 2014. Available online: https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf (accessed on 3 May 2024).
- Jones, K.E.; Patel, N.G.; Levy, M.A.; Storeygard, A.; Balk, D.; Gittleman, J.L.; Daszak, P. Global trends in emerging infectious diseases. Nature 2008, 451, 990–993. [Google Scholar] [CrossRef]
- Cutler, S.J.; Fooks, A.R.; van der Poel, W.H.M. Public Health Threat of New, Reemerging, and Neglected Zoonoses in the Industrialized World. Emerg. Infect. Dis. 2010, 16, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Pepin, M.; Tordo, N. Emerging and re-emerging animal viruses. Foreword. Vet. Res. 2010, 41, 69. [Google Scholar] [PubMed]
- El Amri, H.; Boukharta, M.; Zakham, F.; Ennaji, M.M. Emergence and Reemergence of Viral Zoonotic Diseases: Concepts and Factors of Emerging and Reemerging Globalization of Health Threats. In Emerging and Reemerging Viral Pathogens; Academic Press: Cambridge, MA, USA, 2020; pp. 619–634. [Google Scholar]
- Baker, R.E.; Mahmud, A.S.; Miller, I.F.; Rajeev, M.; Rasambainarivo, F.; Rice, B.L.; Takahashi, S.; Tatem, A.J.; Wagner, C.E.; Wang, L.-F.; et al. Infectious disease in an era of global change. Nat. Rev. Microbiol. 2022, 20, 193–205. [Google Scholar] [CrossRef] [PubMed]
- Sinclair, J. Importance of a One Health approach in advancing global health security and the Sustainable Development Goals. Rev. Sci. Tech. l’OIE 2019, 38, 145–154. [Google Scholar] [CrossRef] [PubMed]
- Cunningham, A.A.; Scoones, I.; Wood, J.L.N. One Health for a changing world: New perspectives from Africa. Philos. Trans. R. Soc. B Biol. Sci. 2017, 372, 20160162. [Google Scholar] [CrossRef] [PubMed]
- Abubakar, I.R. Access to Sanitation Facilities among Nigerian Households: Determinants and Sustainability Implications. Sustainability 2017, 9, 547. [Google Scholar] [CrossRef]
- Yaya, S.; Hudani, A.; Udenigwe, O.; Shah, V.; Ekholuenetale, M.; Bishwajit, G. Improving Water, Sanitation and Hygiene Practices, and Housing Quality to Prevent Diarrhea among Under-Five Children in Nigeria. Trop. Med. Infect. Dis. 2018, 3, 41. [Google Scholar] [CrossRef] [PubMed]
- Akokuwebe, M.E.; Idemudia, E.S. Fraud within the Nigerian health system, a double threat for resilience of a health system and the response to the COVID-19 pandemic: A review. Pan Afr. Med J. 2023, 45, 116. [Google Scholar] [CrossRef]
- Kalbarczyk, A.; Davis, W.; Kalibala, S.; Geibel, S.; Yansaneh, A.; Martin, N.A.; Weiss, E.; Kerrigan, D.; Manabe, Y.C. Research Capacity Strengthening in Sub-Saharan Africa: Recognizing the Importance of Local Partnerships in Designing and Disseminating HIV Implementation Science to Reach the 90–90–90 Goals. AIDS Behav. 2019, 23, 206–213. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Besson, M.E.; Pépin, M.; Metral, P.-A. Lassa Fever: Critical Review and Prospects for Control. Trop. Med. Infect. Dis. 2024, 9, 178. https://doi.org/10.3390/tropicalmed9080178
Besson ME, Pépin M, Metral P-A. Lassa Fever: Critical Review and Prospects for Control. Tropical Medicine and Infectious Disease. 2024; 9(8):178. https://doi.org/10.3390/tropicalmed9080178
Chicago/Turabian StyleBesson, Marianne E., Michel Pépin, and Pierre-Alexandre Metral. 2024. "Lassa Fever: Critical Review and Prospects for Control" Tropical Medicine and Infectious Disease 9, no. 8: 178. https://doi.org/10.3390/tropicalmed9080178